Similarly, greater cytoplasmic HMGB1 expression has been reported in TN and HER-2-positive breast cancers than in HR-positive tumors; in TN breast cancer, this expression, but not nuclear HMGB1 expression, was associated significantly with TIL and CD8+ cell abundance [85]. The gene discussed is ERBB2; the disease is breast carcinoma.